Research progress on siRNA delivery with nonviral carriers

被引：114

作者：

Gao, Yan ^{[1
]}

Liu, Xin-Ling ^{[1
]}

Li, Xiao-Rong ^{[1
]}

机构：

[1] Tianjin Med Univ Eye Ctr, Tianjin, Peoples R China

来源：

INTERNATIONAL JOURNAL OF NANOMEDICINE | 2011年 / 6卷

关键词：

small interfering RNA; nonviral vector; gene therapy; delivery system; nanoparticles; biocompatibility; SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; CHEMICAL-MODIFICATION; GENE DELIVERY; CELLULAR UPTAKE; CATIONIC LIPOSOMES; TARGETED DELIVERY; CANCER-CELLS; IN-VITRO; NANOPARTICLE;

D O I：

10.2147/IJN.S17040

中图分类号：

TB3 [工程材料学];

学科分类号：

082905 [生物质能源与材料];

摘要：

RNA interference is a powerful method for the knockdown of pathologically relevant genes. Small interfering RNAs (siRNAs) have been widely demonstrated as effective biomedical genetic-therapy applications for many diseases. Unfortunately, siRNA duplexes are not ideal drug-like molecules. Problems hindering their effective application fundamentally lie in their delivery, stability, and off-target effects. Delivery systems provide solutions to many of the challenges facing siRNA therapeutics. Due to some fatal disadvantages of viral vectors, nonviral carriers have been studied extensively. Aside from liposomes, nanoparticles and cationic polymer carriers have exhibited improved in vivo stability, better biocompatibility, and efficiency for gene silencing with less cellular toxicity. They may represent a promising strategy for siRNA-based therapies, especially as nanomaterials. The present review also summarizes other methods of siRNA delivery and the side effects of the nanoparticles.

引用

页码：1017 / 1025

页数：9

共 92 条

[1]

A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity [J].

Aberle, AM ;

Tablin, F ;

Zhu, J ;

Walker, NJ ;

Gruenert, DC ;

Nantz, MH .

BIOCHEMISTRY, 1998, 37 (18) :6533-6540

[2]

Functional Delivery of siRNA in Mice Using Dendriworms [J].

Agrawal, Amit ;

Min, Dal-Hee ;

Singh, Neetu ;

Zhu, Haihao ;

Birjiniuk, Alona ;

von Maltzahn, Geoffrey ;

Harris, Todd J. ;

Xing, Deyin ;

Woolfenden, Stephen D. ;

Sharp, Phillip A. ;

Charest, Alain ;

Bhatia, Sangeeta .

ACS NANO, 2009, 3 (09) :2495-2504

[3]

Nonviral Gene Delivery: Principle, Limitations, and Recent Progress [J].

Al-Dosari, Mohammed S. ;

Gao, Xiang .

AAPS JOURNAL, 2009, 11 (04) :671-681

[4]

Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression [J].

Aleku, Manuela ;

Schulz, Petra ;

Keil, Oliver ;

Santel, Ansgar ;

Schaeper, Ute ;

Dieckhoff, Britta ;

Janke, Oliver ;

Endruschat, Jens ;

Durieux, Birgit ;

Roeder, Nadine ;

Loeffler, Kathrin ;

Lange, Christian ;

Fechtner, Melanie ;

Moepert, Kristin ;

Fisch, Gerald ;

Dames, Sibylle ;

Arnold, Wolfgang ;

Jochims, Karin ;

Giese, Klaus ;

Wiedenmann, Bertram ;

Scholz, Arne ;

Kaufmann, Joerg .

CANCER RESEARCH, 2008, 68 (23) :9788-9798

[5]

Barichello JM, 2010, METHODS MOL BIOL, V605, P461, DOI 10.1007/978-1-60327-360-2_32

[6]

Chemical Modification of siRNAs for In Vivo Use [J].

Behlke, Mark A. .

OLIGONUCLEOTIDES, 2008, 18 (04) :305-319

[7]

Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons [J].

Bonoiu, Adela C. ;

Mahajan, Supriya D. ;

Ding, Hong ;

Roy, Indrajit ;

Yong, Ken-Tye ;

Kumar, Rajiv ;

Hu, Rui ;

Bergey, Earl J. ;

Schwartz, Stanley A. ;

Prasad, Paras N. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (14) :5546-5550

[8]

RNA interference in mammalian cells by chemically-modified RNA [J].

Braasch, DA ;

Jensen, S ;

Liu, YH ;

Kaur, K ;

Arar, K ;

White, MA ;

Corey, DR .

BIOCHEMISTRY, 2003, 42 (26) :7967-7975

[9]

A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity [J].

Bramsen, Jesper B. ;

Laursen, Maria B. ;

Nielsen, Anne F. ;

Hansen, Thomas B. ;

Bus, Claus ;

Langkjaer, Niels ;

Babu, B. Ravindra ;

Hojland, Torben ;

Abramov, Mikhail ;

Van Aerschot, Arthur ;

Odadzic, Dalibor ;

Smicius, Romualdas ;

Haas, Jens ;

Andree, Cordula ;

Barman, Jharna ;

Wenska, Malgorzata ;

Srivastava, Puneet ;

Zhou, Chuanzheng ;

Honcharenko, Dmytro ;

Hess, Simone ;

Mueller, Elke ;

Bobkov, Georgii V. ;

Mikhailov, Sergey N. ;

Fava, Eugenio ;

Meyer, Thomas F. ;

Chattopadhyaya, Jyoti ;

Zerial, Marino ;

Engels, Joachim W. ;

Herdewijn, Piet ;

Wengel, Jesper ;

Kjems, Jorgen .

NUCLEIC ACIDS RESEARCH, 2009, 37 (09) :2867-2881

[10]

RNAi therapeutics: a potential new class of pharmaceutical drugs [J].

Bumcrot, David ;

Manoharan, Muthiah ;

Koteliansky, Victor ;

Sah, Dinah W. Y. .

NATURE CHEMICAL BIOLOGY, 2006, 2 (12) :711-719

← 1 2 3 4 5 6 7 8 9 10 →